Trafalgar International (GCAN) Payables (2016 - 2026)
Trafalgar International (GCAN) posted Payables of $7514.0 for Q1 2026, down 11.75% on a QoQ basis from $8514.0 in Q4 2025, and down 93.71% year-over-year from $119401.0 in Q1 2025.
Analysis
Trafalgar International (GCAN) Payables (2016 - 2026) Analysis & Trends
Trafalgar International has reported Payables for 11 years, with the latest figure at $7514.0 in Q1 2026.
- On a quarterly basis, Payables fell 93.71% year-over-year to $7514.0 in Q1 2026; TTM through Mar 2026 was $7514.0, a 93.71% decrease from a year earlier, with the FY2025 full-year figure at $8514.0, down 95.25% from the prior year.
- Payables was $7514.0 for Q1 2026 at Trafalgar International, down from $8514.0 in the prior quarter.
- The five-year high for Payables was $480392.0 in Q1 2022, with the low at $7514.0 in Q1 2026.
- Average Payables over 5 years is $193510.5, with a median of $177855.0 recorded in 2024.
- The sharpest annual moves came in 2022 and 2025: Payables surged 81.01% in 2022, then slumped 95.25% in 2025.
- Over 5 years, Payables stood at $259688.0 in 2022, then slumped by 31.64% to $177531.0 in 2023, then grew by 1.01% to $179316.0 in 2024, then plunged by 95.25% to $8514.0 in 2025, then dropped by 11.75% to $7514.0 in 2026.
- The last three Payables figures came in at $7514.0 (Q1 2026), $8514.0 (Q4 2025), and $22624.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 7.03 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 8.31 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | 88.42 Mn |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 250.40 Mn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 497.80 Mn |
| 10 | Trafalgar International | 217,335.05 | 217,335.05 | - | 7,514.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 7,514.00 |
| Dec 31, 2025 | 8,514.00 |
| Sep 30, 2025 | 22,624.00 |
| Jun 30, 2025 | 20,950.00 |
| Mar 31, 2025 | 119,401.00 |
| Dec 31, 2024 | 179,316.00 |
| Sep 30, 2024 | 177,855.00 |
| Jun 30, 2024 | 176,696.00 |
| Mar 31, 2024 | 177,696.00 |
| Dec 31, 2023 | 177,531.00 |
| Sep 30, 2023 | 210,777.00 |
| Jun 30, 2023 | 248,777.00 |
| Mar 31, 2023 | 249,430.00 |
| Dec 31, 2022 | 259,688.00 |
| Sep 30, 2022 | 321,734.00 |
| Jun 30, 2022 | 450,783.00 |
| Mar 31, 2022 | 480,392.00 |
| Dec 31, 2021 | 380,800.00 |
| Sep 30, 2021 | 307,198.00 |
| Jun 30, 2021 | 261,925.00 |